Healthcare Equities

The companies that provide, support or coordinate medical goods and services. This sector spans a broad range of activities – including the development and manufacture of medical equipment, pharmaceuticals and other treatments. Activities range from research to manufacturing, administration, insurance and facilities management. Our Healthcare research includes healthcare services, healthcare information technology (IT), medical devices, biotechnology, biopharmaceuticals and specialty pharmaceuticals.

Immix Biopharma (NASDAQ: IMMX) – Accelerated NEXICART-2 progress >

Arron Aatkar, PhD | Healthcare | Comment | 2 days ago

Immix Biopharma (NASDAQ: IMMX) – Accelerated NEXICART-2 progress >

Arron Aatkar, PhD | Healthcare | Comment | 2 days ago

SEE ALL COMMENTARY >

Nykode Therapeutics (NYKD)

Latest price

NOK1.79

▾ −0.05 (−2.72)

As at 08/07/2025

Market capitalisation: NOK601m

View equity

QuickView

Healthcare

09.12.24

USD2.88

▾ 0.06 (2.13)

As at 08/07/2025

Market capitalisation: USD96m

View equity

Non client QV

Healthcare

06.05.25

SEK2.22

▾ 0.48 (27.59)

As at 08/07/2025

Market capitalisation: SEK368m

View equity

OpGen (OPGN)

Latest price

—

— 0.00 (0.00)

As at 08/07/2025

Market capitalisation: —

View equity

Update

Healthcare

14.08.23

OpGen — Cash concerns dampen active Q2

Flash note

Healthcare

04.08.23

OpGen — FIND collaboration advances to development

Flash note

Healthcare

21.07.23

EUR2.87

▾ 0.18 (6.69)

As at 08/07/2025

Market capitalisation: EUR212m

View equity

Flash

Healthcare

24.06.25

Oryzon Genomics — A step closer to a new treatment paradigm in BPD

Update

Healthcare

19.05.25

Oryzon Genomics — Preparations in place for an active 2025

Flash

Healthcare

08.05.25

EUR4.92

▾ −0.03 (−0.57)

As at 08/07/2025

Market capitalisation: EUR114m

View equity

Flash

Healthcare

05.06.25

OSE Immunotherapeutics — New UC biomarker underpins growth strategy

Flash

Healthcare

03.06.25

OSE Immunotherapeutics — ASCO 2025 update showcases Tedopi potential

Flash

Healthcare

22.05.25

AUD0.01

— 0.00 (0.00)

As at 08/07/2025

Market capitalisation: AUD10m

View equity

Recce Pharmaceuticals (RCE)

Latest price

AUD0.31

▾ 0.01 (1.64)

As at 08/07/2025

Market capitalisation: AUD90m

View equity

Update

Healthcare

23.04.25

Recce Pharmaceuticals — Funding secured to start Phase III pivotal trials

Team of Research Scientists Working On Computer, with Medical Equipment, Analyzing Blood and Genetic Material Samples with Special Machines in the Modern Laboratory.

Update

Healthcare

28.03.25

Recce Pharmaceuticals — Gearing up for an eventful year for R327G

Flash

Healthcare

20.02.25

SEK10.10

▾ 0.23 (2.33)

As at 08/07/2025

Market capitalisation: SEK1,344m

View equity

Non client QV

Healthcare

10.04.25

CHF11.96

▾ 0.06 (0.50)

As at 08/07/2025

Market capitalisation: CHF161m

View equity

Sareum Holdings (SAR)

Latest price

GBP0.20

▾ −1.25 (−5.95)

As at 08/07/2025

Market capitalisation: GBP27m

View equity

Spotlight — flash

Healthcare

03.06.25

Sareum Holdings — A decisive step towards Phase II

Spotlight — update

Healthcare

10.04.25

Sareum Holdings — Broader pipeline, bigger milestones

Spotlight — flash

Healthcare

14.03.25

USD6.77

▾ 0.04 (0.59)

As at 08/07/2025

Market capitalisation: USD481m

View equity

Update

Healthcare

13.05.25

SIGA Technologies — Another strong period for the order book

Flash

Healthcare

10.04.25

SIGA Technologies — Dividends bring cheer amid market uncertainty

Update

Healthcare

19.03.25

SIGA Technologies — Entering a crucial period for business outlook

See more
content on

SIGA Technologies

Equities

Equities by Sector

Sectors

Thematics

Latest

Decarbonising the built environment – Green materials, greener buildings

The advertising ecosystem – Triangulating perspectives

JPMorgan European Discovery Trust – The power of small

Audiovisual

Latest

bp — capital markets update

bp — Q125 financial results

Vantage: VOF – inside Vietnam’s investment boom (27 June 2025)

About Edison

About Edison

Careers

Healthcare Equities

Nykode Therapeutics (NYKD)

NOK1.79

Nykode Therapeutics — Repositioned to streamline clinical progress

See morecontent on

Okyo Pharma (OKYO)

USD2.88

Okyo Pharma — Targeting underserved corneal diseases

See morecontent on

Oncopeptides (ONCO)

SEK2.22

OpGen (OPGN)

—

OpGen — Cash concerns dampen active Q2

OpGen — FIND collaboration advances to development

OpGen — Feasibility milestone from FIND collaboration

See morecontent on

Oryzon Genomics (ORY)

EUR2.87

Oryzon Genomics — A step closer to a new treatment paradigm in BPD

Oryzon Genomics — Preparations in place for an active 2025

Oryzon Genomics — €13.3m grant improves operating headroom

See morecontent on

OSE Immunotherapeutics (OSE)

EUR4.92

OSE Immunotherapeutics — New UC biomarker underpins growth strategy

OSE Immunotherapeutics — ASCO 2025 update showcases Tedopi potential

OSE Immunotherapeutics — Strategic collaboration in mRNA technologies

See morecontent on

Percheron Therapeutics (PER)

AUD0.01

Recce Pharmaceuticals (RCE)

AUD0.31

Recce Pharmaceuticals — Funding secured to start Phase III pivotal trials

Recce Pharmaceuticals — Gearing up for an eventful year for R327G

Recce Pharmaceuticals — Positive R327G Phase II ABSSSI study results

See morecontent on

Saniona (SANION)

SEK10.10

Saniona — Broad pipeline to address neurological conditions

See morecontent on

Santhera Pharmaceuticals (SANN)

CHF11.96

Sareum Holdings (SAR)

GBP0.20

Sareum Holdings — A decisive step towards Phase II

Sareum Holdings — Broader pipeline, bigger milestones

Sareum Holdings — New fund-raise and licence signal active 2025

See morecontent on

SIGA Technologies (SIGA)

USD6.77

SIGA Technologies — Another strong period for the order book

SIGA Technologies — Dividends bring cheer amid market uncertainty

SIGA Technologies — Entering a crucial period for business outlook

See morecontent on

Subscribe to Edison

See more
content on

See more
content on

See more
content on

See more
content on

See more
content on

See more
content on

See more
content on

See more
content on

See more
content on